Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017135
Chunk: 1

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 1
---
 the factors you should carefully consider before deciding to purchase these securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>___________________________________

The date of this prospectus is November 21, 2025</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                         | Page |
| ABOUT THIS PROSPECTUS                                   |    1 |
| PRESENTATION OF FINANCIAL AND OTHER INFORMATION         |    2 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS    |    4 |
| PROSPECTUS SUMMARY                                      |    5 |
| RISK FACTORS                                            |    9 |
| USE OF PROCEEDS                                         |   10 |
| DIVIDEND POLICY                                         |   11 |
| CAPITALIZATION                                          |   12 |
| SELLING SHAREHOLDERS                                    |   13 |
| DESCRIPTION OF OFFERED SECURITIES AND OUR SHARE CAPITAL |   14 |
| DESCRIPTION OF AMERICAN DEPOSITARY SHARES               |   34 |
| PLAN OF DISTRIBUTION                                    |   48 |
| LEGAL MATTERS                                           |   49 |
| EXPERTS                                                 |   49 |
| WHERE YOU CAN FIND MORE INFORMATION                     |   49 |
| INCORPORATION OF CERTAIN INFORMATION BY REFERENCE       |   49 |
| ENFORCEMENT OF CIVIL LIABILITIES                        |   50 |
| EXPENSES OF THE OFFERING                                |   50 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of
a registration statement that we filed with the Securities and Exchange Commission, or SEC. As permitted by the rules and regulations
of the SEC, the registration statement filed by us includes additional information not contained in this prospectus. You may read the
registration statement and the other reports we file with the SEC at the SEC’s website or its offices described below under the
heading “Where You Can Find More Information”.

You should rely only on the
information contained in this prospectus. We have not authorized any person to provide you with information different from that contained
in this prospectus. This prospectus is not an offer to sell, nor is it seeking an offer to buy, these securities in any state where the
offer or sale is